Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
PETOGEN 150 mg/mL Injection
Limited Market Approval
Each 1 mL contains 150 mg of medroxyprogesterone acetate.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Preservatives: Methylparaben 1,7 mg/mL; Propylparaben 0,19 mg/mL.
Potential Multi-Purpose Technology (MPT):
one injection every 3 months
150 mg every 3 months
The prequalification of Petogen by WHO is underway, and this product has recently obtained ERP, level 3, approval by UNFPA. It has been marketed in a limited number of countries for over two countries.
Download Product Report